Works by Morita, Mitsunori

Results: 13
    1

    Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.

    Published in:
    2017
    By:
    • Satoshi Ikeda;
    • Hiroshige Yoshioka;
    • Satoshi Ikeo;
    • Mitsunori Morita;
    • Naoyuki Sone;
    • Takashi Niwa;
    • Akihiro Nishiyama;
    • Toshihide Yokoyama;
    • Akimasa Sekine;
    • Takashi Ogura;
    • Tadashi Ishida;
    • Ikeda, Satoshi;
    • Yoshioka, Hiroshige;
    • Ikeo, Satoshi;
    • Morita, Mitsunori;
    • Sone, Naoyuki;
    • Niwa, Takashi;
    • Nishiyama, Akihiro;
    • Yokoyama, Toshihide;
    • Sekine, Akimasa
    Publication type:
    journal article
    2
    3
    4

    Association Between Early Immune-related Adverse Events and Clinical Outcomes in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.

    Published in:
    2020
    By:
    • Hosoya, Kazutaka;
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Kumagai, Toru;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Ishida, Tadashi;
    • Hirano, Katsuya;
    • Matsumoto, Hirotaka;
    • Kominami, Ryota;
    • Tomii, Keisuke;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Sawa, Nobuhiko;
    • Makio, Takeshi;
    • Hara, Satoshi
    Publication type:
    journal article
    5

    Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan.

    Published in:
    PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0220570
    By:
    • Ryuya Edahiro;
    • Masaki Kanazu;
    • Hiroyuki Kurebe;
    • Masahide Mori;
    • Daichi Fujimoto;
    • Yoshihiko Taniguchi;
    • Hidekazu Suzuki;
    • Katsuya Hirano;
    • Toshihide Yokoyama;
    • Mitsunori Morita;
    • Yasushi Fukuda;
    • Junji Uchida;
    • Takeshi Makio;
    • Motohiro Tamiya
    Publication type:
    Article
    6

    A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302.

    Published in:
    Oncology, 2019, v. 97, n. 6, p. 327, doi. 10.1159/000501967
    By:
    • Ikeda, Satoshi;
    • Yoshioka, Hiroshige;
    • Kaneda, Toshihiko;
    • Yokoyama, Toshihide;
    • Niwa, Takashi;
    • Sone, Naoyuki;
    • Ishida, Tadashi;
    • Morita, Mitsunori;
    • Tomioka, Hiromi;
    • Komaki, Chihito;
    • Hirabayashi, Masataka;
    • Hasegawa, Yoshinori;
    • Noguchi, Tetsuo;
    • Nakano, Yasutaka;
    • Sakaguchi, Chikara;
    • Yoshimura, Kenichi;
    • Hirai, Toyohiro
    Publication type:
    Article
    7
    8

    A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 5, p. 1, doi. 10.1002/cam4.6968
    By:
    • Komatsu, Hiroaki;
    • Matsumoto, Koji;
    • Morita, Mitsunori;
    • Nagasawa, Takayuki;
    • Nishio, Hiroshi;
    • Suzuki, Jiro;
    • Nishio, Shin;
    • Kobara, Hisanori;
    • Yunokawa, Mayu;
    • Ariyoshi, Kazuya;
    • Hirayama, Takashi;
    • Tokunaga, Hideki;
    • Ukita, Masayo;
    • Yoriki, Kaori;
    • Mori‐Uchino, Mayuyo;
    • Furusawa, Akiko;
    • Togami, Shinichi;
    • Nakamura, Hiroko;
    • Ishikawa, Mitsuya;
    • Satoh, Toyomi
    Publication type:
    Article
    9
    10

    Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002.

    Published in:
    Investigational New Drugs, 2022, v. 40, n. 2, p. 361, doi. 10.1007/s10637-021-01203-5
    By:
    • Tamiya, Motohiro;
    • Fujikawa, Kei;
    • Suzuki, Hidekazu;
    • Yokoyama, Toshihide;
    • Uenami, Takeshi;
    • Tamiya, Akihiro;
    • Sato, Yuki;
    • Saito, Go;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Hirashima, Tomonori;
    • Fukuda, Yasushi;
    • Kanazu, Masaki;
    • Hosoya, Kazutaka;
    • Suzuki, Takuji;
    • Ueno, Kiyonobu;
    • Fujimoto, Daichi;
    • Kumagai, Toru;
    • Teramukai, Satoshi
    Publication type:
    Article
    11

    Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non–small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 1, p. 211, doi. 10.1007/s10637-019-00882-5
    By:
    • Kawachi, Hayato;
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Ishii, Seigo;
    • Hirano, Katsuya;
    • Matsumoto, Hirotaka;
    • Fukuda, Yasushi;
    • Yokoyama, Toshihide;
    • Kominami, Ryota;
    • Fujimoto, Daichi;
    • Hosoya, Kazutaka;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Kanazu, Masaki;
    • Sawa, Nobuhiko;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Makio, Takeshi;
    • Hara, Satoshi;
    • Kumagai, Toru
    Publication type:
    Article
    12

    Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).

    Published in:
    Investigational New Drugs, 2019, v. 37, n. 6, p. 1266, doi. 10.1007/s10637-019-00843-y
    By:
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Hosoya, Kazutaka;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Fukuda, Yasushi;
    • Hirano, Katsuya;
    • Matsumoto, Hirotaka;
    • Kominami, Ryota;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Sawa, Nobuhiko;
    • Kinoshita, Yoshinori;
    • Hara, Satoshi;
    • Kumagai, Toru;
    • Fujimoto, Daichi
    Publication type:
    Article
    13

    Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study.

    Published in:
    2021
    By:
    • Hosoya, Kazutaka;
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Kumagai, Toru;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Ishida, Tadashi;
    • Matsumoto, Hirotaka;
    • Hirano, Katsuya;
    • Kominami, Ryota;
    • Tomii, Keisuke;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Tanaka, Satoshi;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Mori, Masahide;
    • Nagata, Kenji
    Publication type:
    journal article